A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.


OBJECTIVE To assess whether a combination of misoprostol and oxytocin is more beneficial than oxytocin alone in reducing blood loss after vaginal delivery among women with known risk factors for postpartum hemorrhage (PPH). METHODS A randomized, double-blind trial was conducted in a medical college in eastern India among women aged at least 18 years who… (More)
DOI: 10.1016/j.ijgo.2015.06.064